Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation
Authors
Keywords
-
Journal
PEDIATRIC NEPHROLOGY
Volume 26, Issue 4, Pages 613-619
Publisher
Springer Nature
Online
2010-12-02
DOI
10.1007/s00467-010-1708-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
- (2010) M. Noris et al. Clinical Journal of the American Society of Nephrology
- Prophylactic Eculizumab after Renal Transplantation in Atypical Hemolytic–Uremic Syndrome
- (2010) Lothar Bernd Zimmerhackl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics and complement in atypical HUS
- (2010) David Kavanagh et al. PEDIATRIC NEPHROLOGY
- Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation
- (2009) Jean-Claude Davin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Safety and Long-Term Efficacy of Eculizumab in a Renal Transplant Patient with Recurrent Atypical Hemolytic-Uremic Syndrome
- (2009) AMERICAN JOURNAL OF TRANSPLANTATION
- Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
- (2009) S. Heinen et al. BLOOD
- Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
- (2009) I. Moore et al. BLOOD
- Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome
- (2009) C. J. Mache et al. Clinical Journal of the American Society of Nephrology
- Eculizumab for Atypical Hemolytic–Uremic Syndrome
- (2009) Jens Nürnberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome
- (2009) Ralph A. Gruppo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
- (2009) Mieke Delvaeye et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atypical Hemolytic–Uremic Syndrome
- (2009) Marina Noris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
- (2008) V. Fremeaux-Bacchi et al. BLOOD
- Successful Split Liver-Kidney Transplant for Factor H Associated Hemolytic Uremic Syndrome
- (2008) J. M. Saland et al. Clinical Journal of the American Society of Nephrology
- Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation
- (2008) Jean Claude Davin et al. PEDIATRIC NEPHROLOGY
- Hemolytic uremic syndrome recurrence after renal transplantation
- (2008) Chantal Loirat et al. PEDIATRIC TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started